Citius announces a $15.8 million direct offering. The company plans to use the proceeds to support the commercial launch of LYMPHIR™, as well as for general corporate purposes. Ready to turn the market's comeback into steady cash flow? Grab the top 3 stocks to buy right here.

Citius announces a distribution services agreement with Cardinal Health. Cardinal serves as an authorized distributor of record for Citius Oncology, providing specialty pharmaceutical distribution services. Ready to turn the market's comeback into steady cash flow? Grab the top 3 stocks to buy ...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Keybanc analyst Ashley Owens downgraded the rating for Deckers Outdoor Corporation DECK from ...

Citius Pharmaceuticals Inc CTXR shares are trading lower by 14.2% to $3.75 during Wednesday's session after the company announced a $3 million registered direct offering priced at-the-market under Nasdaq rules.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Raymond James analyst Savanthi Syth upgraded the rating for American Airlines Group Inc.